<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0236217</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6077</journal-id>
<journal-id journal-id-type="nlm-ta">Neuropharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-3908</issn>
<issn pub-type="epub">1873-7064</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30998945</article-id>
<article-id pub-id-type="pmc">6500758</article-id>
<article-id pub-id-type="doi">10.1016/j.neuropharm.2019.04.017</article-id>
<article-id pub-id-type="manuscript">NIHMS1527818</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Roles of K<sup>+</sup> and Cation Channels in ORL-1 Receptor-mediated Depression of Neuronal Excitability and Epileptic Activities in the Medial Entorhinal Cortex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Huiming</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Binqi</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Hao-peng</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boyle</surname>
<given-names>Cody A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Saobo</given-names>
</name>
<xref ref-type="corresp" rid="CR1">#</xref>
</contrib>
<aff id="A1">Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND58203, USA</aff>
</contrib-group>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>*</label>
<p id="P1">These authors contributed equally to this work.</p>
</fn>
<corresp id="CR1"><label>#</label>Correspondence: Saobo Lei, Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND58203, USA. Phone: 701-777-4745, Fax: 701-777-4490, <email>saobo.lei@und.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>151</volume>
<fpage>144</fpage>
<lpage>158</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuropharm.2019.04.017-->
<abstract id="ABS1">
<p id="P2">Nociceptin (NOP) is an endogenous opioid-like peptide that selectively activates the opioid receptor-like (ORL-1) receptors. The entorhinal cortex (EC) is closely related to temporal lobe epilepsy and expresses high densities of ORL-1 receptors. However, the functions of NOP in the EC, especially in modulating the epileptiform activity in the EC, have not been determined. We demonstrated that activation of ORL-1 receptors remarkably inhibited the epileptiform activity in entorhinal slices induced by application of picrotoxin or by deprivation of extracellular Mg<sup>2+</sup>. NOP- mediated depression of epileptiform activity was independent of synaptic transmission in the EC, but mediated by inhibition of neuronal excitability in the EC. NOP hyperpolarized entorhinal neurons via activation of K<sup>+</sup> channels and inhibition of cation channels. Whereas application of Ba<sup>2+</sup> at 300 Î¼M which is effective for the inward rectifier K<sup>+</sup> (Kir) channels slightly inhibited NOP- induced hyperpolarization, the current-voltage (I-V) curve of the net currents induced by NOP was linear without showing inward rectification. However, a role of NOP-induced inhibition of cation channels was revealed after inhibition of Kir channels by Ba<sup>2+</sup>. Furthermore, NOP-mediated augmentation of membrane currents was differently affected by application of the blockers selective for distinct subfamilies of Kir channels. Whereas SCH23390 or ML133 blocked NOP- induced augmentation of membrane currents at negative potentials, application of tertiapin-Q exerted no actions on NOP-induced alteration of membrane currents. Our results demonstrated a novel cellular and molecular mechanism whereby activation of ORL-1 receptors depresses epilepsy.</p>
</abstract>
<kwd-group>
<kwd>hyperpolarization</kwd>
<kwd>hippocampus</kwd>
<kwd>synaptic transmission</kwd>
<kwd>glutamate</kwd>
<kwd>K<sup>+</sup> channels</kwd>
<kwd>epilepsy</kwd>
<kwd>action potential</kwd>
<kwd>cortex</kwd>
<kwd>neuropeptide</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>